Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial

Predicting Adverse Events beyond Stroke and Bleeding with the ABC-Stroke and ABC-Bleeding Scores in Patients with Atrial Fibrillation: The Murcia AF Project

(2020) Anny Camelo-Castillo et al.   THROMBOSIS AND HAEMOSTASIS

Growth Differentiation Factor-15 Provides Prognostic Information Superior to Established Cardiovascular and Inflammatory Biomarkers in Unselected Patients Hospitalized with COVID-19

(2020) Peder L. Myhre et al.   CIRCULATION

2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)

(2020) Gerhard Hindricks et al.   EUROPEAN HEART JOURNAL

Low-Dose Edoxaban in Very Elderly Patients with Atrial Fibrillation

(2020) Ken Okumura et al.   NEW ENGLAND JOURNAL OF MEDICINE

Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48

(2019) David Douglas Berg et al.   CIRCULATION

Relationship of Aging and Incident Comorbidities to Stroke Risk in Patients With Atrial Fibrillation

(2018) Tze-Fan Chao et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Antithrombotic Therapy for Atrial Fibrillation

(2018) Gregory Y.H. Lip et al.   CHEST

Long-term bleeding risk prediction in ‘real world’ patients with atrial fibrillation: Comparison of the HAS-BLED and ABC-Bleeding risk scores

(2017) Vanessa Roldán et al.   THROMBOSIS AND HAEMOSTASIS

Repeated Measurements of Cardiac Biomarkers in Atrial Fibrillation and Validation of the ABC Stroke Score Over Time

(2017) Ziad Hijazi et al.   Journal of the American Heart Association

The ABC (age, biomarkers, clinical history) stroke risk score: a biomarker-based risk score for predicting stroke in atrial fibrillation

(2016) Ziad Hijazi et al.   EUROPEAN HEART JOURNAL

The novel biomarker-based ABC (age, biomarkers, clinical history)-bleeding risk score for patients with atrial fibrillation: a derivation and validation study

(2016) Ziad Hijazi et al.   LANCET

Cardiovascular Biomarker Score and Clinical Outcomes in Patients With Atrial Fibrillation

(2016) Christian T. Ruff et al.   JAMA Cardiology

Growth Differentiation Factor 15, a Marker of Oxidative Stress and Inflammation, for Risk Assessment in Patients With Atrial Fibrillation

(2014) Lars Wallentin et al.   CIRCULATION

Importance of persistent elevation of cardiac biomarkers in atrial fibrillation: a RE-LY substudy

(2014) Ziad Hijazi et al.   HEART

Biomarkers in atrial fibrillation: a clinical review

(2013) Z. Hijazi et al.   EUROPEAN HEART JOURNAL

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

(2013) Robert P. Giugliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serial Measurement of Growth-Differentiation Factor-15 in Heart Failure

(2010) Inder S. Anand et al.   CIRCULATION

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE